Skip to content

Immatics

US · IMTX #3173 by market cap Listed 2018
5.77 -0.18 -3.03%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

Price chart

Pre-market 6.29 +5.71%
After-hours 5.88 +1.91%
11.515.775.772026-05-262026-11-20
MA5MA10MA20MA60
— MA5 — MA10 — MA20 — MA60
Reader sentiment Are you bullish or bearish on IMTX?

Anonymous reader poll. Unscientific, not investment advice.

✦ StockVane Quant Insights how this is computed

Quant Sentiment Neutral
  • Recent price momentum is -37.7% on average (3-month/1-year).
  • Main-fund capital flow has been a net outflow over the last 45 sessions.
  • Short interest has fallen to 2.5% of float.
  • Analyst tilt is Buy.
Quant Technical Outlook Bearish
  • Price is below its 20-day average and below its 60-day average.
  • The 20-day average is below the 60-day average, a short-term downtrend.
Quant Rating, last 30 days E → E

Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.

Factor grades

Ranked against 2848 U.S. stocks StockVane covers.

Last computed: 2026-11-22 08:27 UTC

Data coverage: 5 of 6 factors. Missing data is not a zero score.

Overall D+

The radar needs all six factors. Available grades are shown below.

Valuation N/A

How expensive the stock is versus earnings, sales and its own 5-year history.

Not enough data to grade this factor.

Growth D+

How fast revenue, profit and free cash flow are compounding.

Revenue CAGR (3Y) -34.6% Better than 1%
Free cash flow CAGR (3Y) 11.0% Better than 54%
Profitability D-

How much profit the business keeps from each dollar of sales and capital.

Operating margin -377.1% Better than 4%
Net margin -407.0% Better than 4%
Return on equity -37.1% Better than 11%
Return on invested capital -39.0% Better than 8%
Momentum D-

Recent price strength, skipping the latest month to avoid short-term noise.

3-month return -35.4% Better than 14%
6-month return -50.3% Better than 7%
12-month return (ex latest month) -28.3% Better than 10%
Distance below 52-week high 53.5% Better than 16%
Financial Health A-

Balance-sheet strength: leverage, liquidity and interest coverage.

Current ratio 11.7x Better than 95%
Debt to assets 2.8% Better than 85%
Interest coverage -208.8x Better than 4%
Free cash flow / net income 250.3% Better than 82%
Analyst View A+

What the Street thinks: share of Buy ratings and upside to the average target.

Analysts rating Buy 100.0% Better than 77%
Upside to average target 173.1% Better than 92%

Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector. Background recomputation is scheduled every 6 hours; actual computation time is shown above, and source datasets have different reporting dates. Not investment advice or tailored to your financial situation.

Performance

1W -9.70%
1M -23.17%
3M -32.51%
6M -48.57%
YTD -45.05%
1Y -42.87%
3Y -32.83%
5Y -51.47%

Key statistics

Price & volume

Prev close
5.95
Open
5.86
Day range
5.72 - 5.95
Avg price
5.78
Volume
746.75K
Turnover
4.32M
Amplitude
3.95%
52-week range
5.72 - 12.41

Valuation

P/E
-3.27
P/E (TTM)
-3.13
P/B
1.83
EPS
-1.77
Net profit
-268.90M
Net assets
480.86M

Share structure

Market cap
878.58M
Float cap
495.19M
Shares out
152.27M
Float shares
85.82M

Dividend & listing

Dividend (TTM)
0.00
Listing date
2018-10-05
52-week range 1% of range
5.72 12.41

53.5% below the 52-week high

Trading activity

Net capital flow main funds, last 45 sessions

-14.36M net over the window

Short interest

Shares short
3.67M
As of
2026-10-30

Frequently asked questions

What is the current stock price of Immatics (IMTX)?

Immatics last traded at 5.77. This page shows a periodic quote snapshot. Check the displayed quote time.

What is Immatics's market cap?

About 878.58M.

What is the P/E ratio of Immatics?

The trailing twelve-month P/E is -3.13. The Valuation tab shows it against the stock's own five-year range.

Does Immatics pay a dividend?

Immatics does not currently pay a regular dividend.

Is Immatics a buy according to analysts?

The consensus of 6 analysts is a Buy rating, with an average 12-month price target of 15.76, which implies 173.1% upside from the current price. This is not investment advice.

What is Immatics's StockVane Quant Rating?

The StockVane Momentum strategy currently rates Immatics a E (Strong Sell). Below its 200-day average and near the bottom of the universe on momentum. Not investment advice.

Quote time 2026-11-20 19:30:05 · For reference only, not investment advice and not tailored to your situation.

Immatics discussion 0 comments

Add a comment